VeriSIM Life Company

VeriSIM Life is a computational bioplatform that predicts the clinical outcomes of new drugs before clinical trials. VeriSIM offers a range of translational-based solutions, customized for the pre-clinical and clinical programs. These offerings are all centered around their proven and validated BIOiSIMTM platform for small molecules, large molecules, and viruses.
Technology: Artificial Intelligence, Health Care, Machine Learning, SaaS
Industry: Preclinical Development
Headquarters: San Francisco, California, United States
Founded Date: 2017-01-01
Employees Number: 11-50
Funding Status: Early Stage Venture
Investors Number: 15
Total Funding: 21655908
Estimated Revenue: $1M to $10M
Last Funding Date: 2022-01-13
Last Funding Type: Series A

Visit Website
Register and Claim Ownership